Bezpieczeństwo immunoterapii alergenowej u dzieci i młodzieży – analiza danych z Allergen Immunotherapy Adverse Reactions Registry

Omówienie artykułu: Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies – report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce.

Clinical and Translational Allergy, 2023; 13: e12250.